News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
ory
ORYZON reports results and corporate update for quarter ended March 31, 2022
Healthcare
Oryzon Genomics, S.A., today reported financial results for the first quarter of 2022 and provided…
Partners - Oryzon Genomics
bcn
Conference “Jornada de Acceso al Mercado de Medicamentos, Tratamientos de Coste Elevado y Medición de Resultados en Salud”
Healthcare
BCN HEALTH is organising the conference “Jornada de Acceso al Mercado de Medicamentos, Tratamientos…
Partners - BCN Health
jj
Digital Therapeutics Leader Sidekick Raises $55M Series B To Drive Further Growth
Financing
The closing of the company’s B Series follows an oversubscribed $20m A round in 2020
Partners - Asabys Partners
Rosa Planelles
“AseBio Investor Day 2022 showcased a bubbling biotech sector”
International · Financing · Digitalization
It’s been a week since AseBio’s event of the year, which brought together some 145 organisations…
Celtarys
#NewMember | "AseBio is a reference in the promotion and visibility of the biotech sector in Spain"
Healthcare · Drug discovery
Meet Celtarys Research, our new member. We talk with Sonia…
AseBio - Celtarys Research
jjj
El 52% de los hombres españoles considera que los problemas de salud masculinos son un tema tabú
Healthcare
De entre las distintas patologías, confiesan que se sienten menos cómodos al hablar de salud sexual…
Partners - Merck
ww
ORYZON starts preclinical collaboration on Kabuki syndrome with Kennedy Krieger Institute and Johns Hopkins University
Healthcare
Oryzon Genomics, S.A, announced today the start of a preclinical collaboration on Kabuki…
Partners - Oryzon Genomics
ee
Integra Therapeutics appoints Mark Bonyhadi as new independent director
Corporate
Dr Mark Bonyhadi is an experienced executive with over 30 years in the biopharmaceutical industry
Partners - Integra Therapeutics S.L.
genesis
GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will invest in early stage projects from healthcare research
Corporate
GENESIS Biomed and FI Group create GENESIS Tech Transfer Boost, a new investment vehicle that will…
Partners - GENESIS Biomed